Specialists in Gastroenterology and GI Alliance Begin Prescribing Groundbreaking Rezdiffra for Fatty Liver Disease
June 26, 2024 08:30 ET
|
GI Alliance
St. Louis, MO, June 26, 2024 (GLOBE NEWSWIRE) -- Specialists in Gastroenterology (SIG) and GI Alliance are excited to announce that Dr. Leonard Weinstock and other GI Alliance gastroenterologists...
US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
April 05, 2024 09:17 ET
|
Spherix Global Insights
EXTON, PA, April 05, 2024 (GLOBE NEWSWIRE) -- As the first treatment to gain FDA approval for metabolic dysfunction-associated steatohepatitis (MASH), Madrigal Pharmaceuticals’ Rezdiffra...